Molecule
Molecule is a decentralized biotechnology protocol porting intellectual property into Web3. A decentralized biopharma marketplace, Molecule connects scientists, patients and industry to advance drug development in a collaborative open market. The company propels science from lab to life, fueled by a community committed to human progress. By utilizing blockchain technology, Molecule facilitates the tokenization of intellectual property, transforming them into liquid, tradable assets or IPTs. The company is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients.
ABOUT MOLECULE
Molecule is a platform where medical research projects can receive funding via decentralized autonomous organizations.
Molecule is part of a nascent movement called decentralized science (DeSci) that emerged from Web3.
The company utilizes biotechnology and translational research to accelerate innovation in the pharmaceutical industry.
The platform empowers researchers, patients, and investors to collaboratively fund, govern, and promote scientific innovation.
The platform connects leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset.
PRODUCTS
Catalyst.
Catalyst fuels scientific advancements through democratized research funding and tokenized intellectual property.
IP-NFT.
It unifies intellectual property, underlying data, and economics into one programmable, transactable, digital unit. With IP-NFTs, collectives of enthusiastic contributors are able to pool resources, connect with researchers.
IPTs.
They are the natural next step in decentralizing drug development, allowing individuals to directly interact with, and govern the IP produced by world-class scientists.